Si Moon Hwang - Net Worth and Insider Trading

Si Moon Hwang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Si Moon Hwang owns 2 companies in total, including Rexahn Pharmaceuticals Inc (REXN) , and Ocuphire Pharma Inc (OCUP) .

Click here to see the complete history of Si Moon Hwang’s form 4 insider trades.

Insider Ownership Summary of Si Moon Hwang

Ticker Comapny Transaction Date Type of Owner
REXN Rexahn Pharmaceuticals Inc 2014-06-09 director
OCUP Ocuphire Pharma Inc 2012-06-18 director

Si Moon Hwang Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Si Moon Hwang Ownership Network

Ownership Network List of Si Moon Hwang

No Data

Ownership Network Relation of Si Moon Hwang

Insider Network Chart

Si Moon Hwang Owned Company Details

What does Rexahn Pharmaceuticals Inc do?

Who are the key executives at Rexahn Pharmaceuticals Inc?

Si Moon Hwang is the director of Rexahn Pharmaceuticals Inc. Other key executives at Rexahn Pharmaceuticals Inc include Chief Medical Officer Ely Benaim , Chief Business Officer Lisa Nolan , and director & President and CEO Douglas J Swirsky .

Rexahn Pharmaceuticals Inc (REXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Rexahn Pharmaceuticals Inc (REXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rexahn Pharmaceuticals Inc (REXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Rexahn Pharmaceuticals Inc (REXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rexahn Pharmaceuticals Inc Insider Transactions

No Available Data

Si Moon Hwang Mailing Address

Above is the net worth, insider trading, and ownership report for Si Moon Hwang. You might contact Si Moon Hwang via mailing address: 202-306 Line Apt Bongseon-dong, Nam-gu, Gwangju M4 503.

Discussions on Si Moon Hwang

No discussions yet.